Wednesday, November 14, 2018 7:17:19 AM
The after-tax net loss in the quarter, inclusive of non-cash share-compensation expenses, fair value impacts and other non-cash expenses as described above amounted to a loss of $330.6 million or $1.52 per basic share compared to a net loss of $1.6 million or $0.01 per basic and diluted share in the comparative period last year.
Year-to-date, the after-tax net loss, inclusive of non-cash share-compensation expenses, fair value impacts and other expenses as described above, amounted to a loss of $421.6 million or $1.98 per basic share compared to a net loss of $10.8 million or $0.07 per basic share in the comparative period last year.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM